ICD-9-CM Changes Effective 10/1/2004-9/30/2005 Source: Federal Register Thursday, August 11, 2004
| Table 6A - New Diagnosis Codes | ||||
| Diagnosis | ||||
| Code | Description | CC | MDC | DRG |
| 66.40 | West Nile Fever, unspecified | N | 18 | 421,422 |
| 66.41 | West Nile Fever with encephalitis | N | 18 | 421,422 |
| 66.42 | West Nile Fever with other neurologic manifestation | N | 18 | 421,422 |
| 66.49 | West Nile Fever with other complications | N | 18 | 421,422 |
| 70.70 | Unspecified viral hepatitis C without hepatic coma | Y |
7 | 205,206 |
| 70.71 | Unspecified viral hepatitis C with hepatic coma | Y | 7 | 205,206 |
| 252.00 | Hyperparathyroidism, unspecified | N | 10 | 300,301 |
| 252.01 | Primary hyperparathyroidism | N | 10 | 300,301 |
| 252.02 | Secondary hyperparathyroidism, non-renal | N | 10 | 300,301 |
| 252.08 | Other hyperparathyroidism | N | 10 | 300,301 |
| 273.40 | Alpha-I-antitrypsin deficiency | N | 10 | 299 |
| 277.85 | Disorders of fatty acid oxidation | N | 10 | 299 |
| 277.86 | Peroxisomal disorders | N | 10 | 299 |
| 277.87 | Disorders of mitochondrial metabolism | N | 10 | 299 |
| 347.00 | Narcolepsy, without cataplexy | N | 1 | 34,35 |
| 347.01 | Narcolepsy, with cataplexy | N | 1 | 34,35 |
| 347.10 | Narcolepsy in conditions classified elsewhere, without cataplexy | N | 1 | 34,35 |
| 347.11 | Narcolepsy in conditions classified elsewhere, with cataplexy | N | 1 | 34,35 |
| 380.03 | Chondritis of pinna | N | 8 | 256 |
| 453.40 | Venous embolism and thrombosis of unspecified deep vessels of lower extremity | Y | 5 | 130, 131 |
| 453.41 | Venous embolism and thrombosis of deep vessels of proximal lower extremity | Y | 5 | 130, 131 |
| 453.42 | Venous embolism and thrombosis of deep vessels of distal lower extremity | Y | 5 | 130, 131 |
| 477.20 | Allergic rhinitis, due to animal (cat) (dog) hair and dander | N | 3 | 68,69,70 |
| 491.22 | Obstructive chronic bronchitis with acute bronchitis | Y |
4 | 88 |
| 521.06 | Dental caries pit and fissure | N | PRE3 | 482,185, 186, 187 |
| 521.07 | Dental caries of smooth surface | N | PRE 3 | 482,185, 186, 187 |
| 521.08 | Dental caries of root surface | N | PRE 3 | 482,185, 186, 187 |
| 521.10 | Excessive attrition, unspecified | N | PRE 3 | 482,185, 186, 187 |
| 521.11 | Excessive attrition, limited to enamel | N | PRE 3 | 482,185, 186, 187 |
| 521.12 | Excessive attrition, extending into dentine | N | PRE 3 | 482,185, 186, 187 |
| 521.13 | Excessive attrition, extending into pulp | N | PRE 3 | 482,185, 186, 187 |
| 521.14 | Excessive attrition, localized | N | PRE 3 | 482,185, 186, 187 |
| 521.15 | Excessive attrition, generalized | N | PRE 3 | 482,185, 186, 187 |
| 521.20 | Abrasion, unspecified | N | PRE 3 | 482,185, 186, 187 |
| 521.21 | Abrasion, limited to enamel | N | PRE 3 | 482,185,186, 187 |
| 521.22 | Abrasion, extending into dentine | N | PRE 3 | 482,185,186, 187 |
| 521.23 | Abrasion, extending into pulp | N | PRE 3 | 482,185, 186, 187 |
| 521.24 | Abrasion, localized | N | PRE 3 | 482,185, 186, 187 |
| 521.25 | Abrasion, generalized | N | PRE 3 | 482,185, 186, 187 |
| 521.30 | Erosion, unspecified | N | PRE 3 | 482,185, 186, 187 |
| 521.31 | Erosion, limited to enamel | N | PRE 3 | 482,185, 186, 187 |
| 521.32 | Erosion, extending into dentine | N | PRE 3 | 482,185, 186, 187 |
| 521.33 | Erosion, extending into pulp | N | PRE 3 | 482,185, 186, 187 |
| 521.34 | Erosion, localized | N | PRE 3 | 482,185, 186, 187 |
| 521.35 | Erosion, generalized | N | PRE 3 | 482,185, 186, 187 |
| 521.40 | Pathological resorption, unspecified | N | PRE 3 | 482,185, 186, 187 |
| 521.41 | Pathological resorption, internal | N | PRE 3 | 482,185, 186, 187 |
| 521.42 | Pathological resorption, external | N | PRE 3 | 482,185, 186, 187 |
| 521.49 | Other pathological resorption | N | PRE 3 | 482,185, 186, 187 |
| 523.20 | Gingival recession, unspecified | N | PRE 3 | 482,185, 186, 187 |
| 523.21 | Gingival recession, minimal | N | PRE 3 | 482,185, 186, 187 |
| 523.22 | Gingival recession, moderate | N | PRE 3 | 482,185, 186, 187 |
| 523.23 | Gingival recession, severe | N | PRE 3 | 482,185, 186, 187 |
| 523.24 | Gingival recession, localized | N | PRE 3 | 482,185, 186, 187 |
| 523.25 | Gingival recession, generalized | N | PRE 3 | 482,185, 186, 187 |
| 524.07 | Excessive tuberosity of jaw | N | PRE 3 | 482,185, 186, 187 |
| 524.20 | Unspecified anomaly of dental arch relationship | N | PRE 3 | 482,185, 186, 187 |
| 524.21 | Angle's class I | N | PRE 3 | 482,185, 186, 187 |
| 524.22 | Angle's class II | N | PRE 3 | 482,185, 186, 187 |
| 524.23 | Angle's class III | N | PRE 3 | 482,185, 186, 187 |
| 524.24 | Open anterior occlusal relationship | N | PRE 3 | 482,185, 186, 187 |
| 524.25 | Open posterior occlusal relationship | N | PRE 3 | 482,185, 186, 187 |
| 524.26 | Excessive horizontal overlap | N | PRE 3 | 482,185, 186, 187 |
| 524.27 | Reverse articulation | N | PRE 3 | 482,185, 186, 187 |
| 524.28 | Anomalies of interarch distance | N | PRE 3 | 482,185, 186, 187 |
| 524.29 | Other anomalies of dental arch relationship | N | PRE 3 | 482,185, 186, 187 |
| 524.30 | Unspecified anomaly of tooth position | N | PRE 3 | 482,185, 186, 187 |
| 524.31 | Crowding of teeth | N | PRE 3 | 482,185, 186, 187 |
| 524.32 | Excessive spacing of teeth | N | PRE 3 | 482,185, 186, 187 |
| 524.33 | Horizontal displacement of teeth | N | PRE 3 | 482,185, 186, 187 |
| 524.34 | Vertical displacement of teeth | N | PRE 3 | 482,185, 186, 187 |
| 524.35 | Rotation of teeth | N | PRE 3 | 482,185, 186, 187 |
| 524.36 | Insufficient interocclusal distance of teeth (ridge) | N | PRE 3 | 482,185, 186, 187 |
| 524.37 | Excessive interocclusal distance of teeth | N | PRE 3 | 482,185, 186, 187 |
| 524.39 | Other anomalies of tooth position | N | PRE 3 | 482,185, 186, 187 |
| 524.50 | Dentofacial functional abnormality, unspecified | N | PRE 3 | 482,185, 186, 187 |
| 524.51 | Abnormal jaw closure | N | PRE 3 | 482,185, 186, 187 |
| 524.52 | Limited mandibular range of motion | N | PRE 3 | 482,185, 186, 187 |
| 524.53 | Deviation in opening and closing of the mandible | N | PRE 3 | 482,185, 186, 187 |
| 524.54 | Insufficient anterior guidance | N | PRE 3 | 482,185, 186, 187 |
| 524.55 | Centric occlusion maximum intercuspation discrepancy | N | PRE 3 | 482,185, 186, 187 |
| 524.56 | Non-working side interference | N | PRE 3 | 482,185, 186, 187 |
| 524.57 | Lack of posterior occlusal support | N | PRE 3 | 482,185, 186, 187 |
| 524.59 | Other dentofacial functional abnormalities | N | PRE 3 | 482,185, 186, 187 |
| 524.64 | Temporomandibular joint sounds on opening and/or closing the jaw | N | PRE 3 | 482,185, 186, 187 |
| 524.75 | Vertical displacement of alveolus and teeth | N | PRE 3 | 482,185, 186, 187 |
| 524.76 | Occlusal plane deviation | N | PRE 3 | 482,185, 186, 187 |
| 524.81 | Anterior soft tissue impingement | N | PRE 3 | 482,185, 186, 187 |
| 524.82 | Posterior soft tissue impingement | N | PRE 3 | 482,185, 186, 187 |
| 524.89 | Other specified dentofacial anomalies | N | PRE 3 | 482,185, 186, 187 |
| 525.20 | Unspecified atrophy of edentulous alveolar ridge | N | PRE 3 | 482,185, 186, 187 |
| 525.21 | Minimal atrophy of the mandible | N | PRE 3 | 482,185, 186, 187 |
| 525.22 | Moderate atrophy of the mandible | N | PRE 3 | 482,185, 186, 187 |
| 525.23 | Severe atrophy of the mandible | N | PRE 3 | 482,185, 186, 187 |
| 525.24 | Minimal atrophy of the maxilla | N | PRE 3 | 482,185, 186, 187 |
| 525.25 | Moderate atrophy of the maxilla | N | PRE 3 | 482,185, 186, 187 |
| 525.26 | Severe atrophy of the maxilla | N | PRE 3 | 482,185, 186, 187 |
| 528.71 | Minimal keratinized residual ridge mucosa | N | PRE 3 | 482,185, 186, 187 |
| 528.72 | Excessive keratinized residual ridge mucosa | N | PRE 3 | 482,185, 186, 187 |
| 528.79 | Other disturbances of oral epithelium, including tongue | N | PRE 3 | 482,185, 186, 187 |
| 530.86 | Infection of esophagostomy | y | 6 | 188, 189, 190 |
| 530.87 | Mechanical complication of esophagostomy | y | 6 | 188, 189, 190 |
| 588.81 | Secondary hyperparathyroidism (of renal origin) | N | 11 | 331,332,333 |
| 588.89 | Other specified disorders resulting from impaired renal function | N | 11 | 331,332,333 |
| 618.00 | Unspecified prolapse of vaginal walls | N | 13 | 358,359,369 |
| 618.01 | Cystocele, midline | N | 13 | 358,359,369 |
| 618.02 | Cystocele, lateral | N | 13 | 358,359,369 |
| 618.03 | Urethrocele | N | 13 | 358,359,369 |
| 618.04 | Rectocele | N | 13 | 358,359,369 |
| 618.05 | Perineocele | N | 13 | 358,359,369 |
| 618.09 | Other prolapse of vaginal walls without mention of uterine prolapse | N | 13 | 358,359,369 |
| 618.81 | Incompetence or weakening of pubocervical tissue | N | 13 | 358,359,369 |
| 618.82 | Incompetence or weakening of rectovagina1 tissue | N | 13 | 358,359,369 |
| 618.83 | Pelvic muscle wasting | N | "13 | 358,359,369 |
| 618.89 | Other specified genital prolapse | N | 13 | 358,359,369 |
| 621.30 | Endometrial hyperplasia, unspecified | N | 13 | 358,359,369 |
| 621.31 | Simple endometrial hyperplasia without atypia | N | 13 | 358,359,369 |
| 621.32 | Complex endometrial hyperplasia without atypia | N | 13 | 358,359,369 |
| 621.33 | Endometrial hyperplasia with atypia | N | 13 | 358,359,369 |
| 622.10 | Dysplasia of cervix, unspecified | N | 13 | 358,359,369 |
| 622.11 | Mild dysplasia of cervix | N | 13 | 358,359,369 |
| 622.12 | Moderate dysplasia of cervix | N | 13 | 358,359,369 |
| 629.20 | Female genital mutilation status, unspecified | N | 13 | 358,359,369 |
| 629.21 | Female genital mutilation Type I status | N | 13 | 358,359,369 |
| 629.22 | Female genital mutilation Type II status | N | 13 | 358,359,369 |
| 629.23 | Female genital mutilation Type III status | N | 13 | 358,359,369 |
| 692.84 | Contact dermatitis and other eczema due to animal (cat) (dog) dander | N | 9 | 283,284 |
| 705.21 | Primary focal hyperhidrosis | N | 9 | 283,284 |
| 705.22 | Secondary focal hyperhidrosis | N | 9 | 283,284 |
| 5 | 1211 | |||
| 707.00 | Decubitus ulcer, unspecified site | Y |
9 | 263,264,271 |
| 5 | 1211 | |||
| 707.01 | Decubitus ulcer, elbow | Y |
9 | 263,264,271 |
| 5 | 1211 | |||
| 707.02 | Decubitus ulcer, upper back | Y |
9 | 263,264,271 |
| 5 | 1211 | |||
| 707.03 | Decubitus ulcer, lower back | Y |
9 | 263,264,271 |
| 5 | 1211 | |||
| 707.04 | Decubitus ulcer, hip | Y |
9 | 263,264,271 |
| 5 | 1211 | |||
| 707.05 | Decubitus ulcer, buttock | Y |
9 | 263,264,271 |
| 5 | 1211 | |||
| 707.06 | Decubitus ulcer, ankle | Y |
9 | 263,264,271 |
| 5 | 1211 | |||
| 707.07 | Decubitus ulcer, heel | Y |
9 | 263,264,271 |
| 5 | 1211 | |||
| 707.09 | Decubitus ulcer, other site | Y |
9 | 263,264,271 |
| 758.31 | Cri-du-chat syndrome | N | 19 | 429 |
| 758.32 | V elo-cardio- facial syndrome | N | 19 | 429 |
| 758.33 | Other microdeletions | N | 19 | 429 |
| 758.39 | Other autosomal deletions | N | 19 | 429 |
| 780.58 | Sleep related movement disorder | N | 19 | 432 |
| 788.38 | Overflow incontinence | N | 11 | 325,326,327 |
| 790.95 | Elevated C-reactive protein (CRP) | N | 23 | 463,464 |
| 795.03 | (LGSIL)Papanicolaou smear of cervix with low grade squamous intraepithelial lesion | N | 13 | 358,359,369 |
| 795.04 | (HGSIL)Papanicolaou smear of cervix with high grade squamous intraepitheliallesion | N | 13 | 358,359,369 |
| 795.05 | Cervical high risk human papilIomavirus (HPV) DNA test positive | N | 13 | 358,359,369 |
| 795.08 | Nonspecific abnormal papanicolaou smear of cervix, unsatisfactory smear | N | 13 | 358,359,369 |
| 796.60 | Nonspecific abnormal findings on neonatal screening | N | 23 | 463,464 |
| V01.71 | Contact or exposure to varicella | N | 23 | 467 |
| V01.79 | Contact or exposure to other viral diseases | N | 23 | 467 |
| V01.83 | Contact or exposure to escherichia coli (E. coli) | N | 23 | 467 |
| V01.84 | Contact or exposure to meningococcus | N | 23 | 467 |
| V46.11 | Dependence on respirator, status | Y | 23 | 467 |
| V46.12 | Encounter for respirator dependence during power failure | Y |
23 | 467 |
| V49.83 | A waiting organ transplant status | Y | 23 | 467 |
| V58.44 | Aftercare following organ transplant | N | 23 | 465-466 |
| V58.66 | Long-term (current) use of aspirin | N | 23 | 465-466 |
| V58.67 | Long-term (current) use of insulin | N | 23 | 465-466 |
| V69.4 | Lack of adequate sleep | N | 23 | 467 |
| V72.31 | Routine gynecological examination | N | 23 | 467 |
| V72.32 | Encounter for Papanicolaou cervical smear to confirm findings of recent normal smear following initial abnormal smear | N | 23 | 467 |
| V72.40 | Pregnancy examination or test, pregnancy unconfirmed | N | 23 | 467 |
| V72.41 | Pregnancy examination or test, negative result | N | 23 | 467 |
| V84.01 | Genetic susceptibility to malignant neoplasm of breast | N | 23 | 467 |
| V84.02 | Genetic susceptibility to malignant neoplasm of ovary | N | 23 | 467 |
| V84.03 | Genetic susceptibility to malignant neoplasm of prostate | N | 23 | 467 |
| V84.04 | Genetic susceptibility to malignant neoplasm of endometrium | N | 23 | 467 |
| V84.09 | Genetic susceptibility to other malignant neoplasm | N | 23 | 467 |
| V84.8 | Genetic susceptibility to other disease | N | 23 | 467 |
| TABLE 6B--NEW PROCEDURE CODES | ||||
| Procedure | ||||
| Code | Description | OR | MDC | DRG |
| 0.16 | Pressurized treatment of venous bypass graft | N | ||
| [conduit] with pharmaceutical substance | ||||
| 0.17 | Infusion of vasopressor agent | N | ||
| 0.21 | Intravascular imaging of extracranial | N | ||
| cerebral vessels | ||||
| 0.22 | Intravascular imaging of intrathoracic | N | ||
| vessels | ||||
| 0.23 | Intravascular imaging of peripheral vessels | N | ||
| 0.24 | Intravascular imaging of coronary vessels | N | ||
| 0.25 | Intravascular imaging of renal vessels | N | ||
| 0.28 | Intravascular imaging, other specified | N | ||
| vessel(s) | ||||
| 0.29 | Intravascular imaging, unspecified vessel(s) | N | ||
| 0.31 | Computer assisted surgery with CT/CT A | N | ||
| 0.32 | Computer assisted surgery with MR/MRA | N | ||
| 0.33 | Computer assisted surgery with fluoroscopy | N | ||
| 0.34 | Imageless computer assisted surgery | N | ||
| 0.35 | Computer assisted surgery with multiple datasets | N | ||
| 0.39 | Other computer assisted surgery | N | ||
| 0.61 | Percutaneous angioplasty or atherectomy of | Y | 1 | 533,534 |
| pre cerebral (extracranial) vessel(s) | 5 | 478,479 | ||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 0.62 | Percutaneous angioplasty or atherectomy of | Y | 1 | 533,534 |
| intracranial vessel(s) | 5 | 478,479 | ||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 0.63 | Percutaneous insertion of carotid artery stent( s ) | N | ||
| 0.64 | Percutaneous insertion of other precerebral(extracranial) artery stent(s) | N | ||
| 0.65 | Percutaneous insertion of intracranial vascular stent(s) | N | ||
| 0.91 | Transplant from live related donor | N | ||
| 0.92 | Transplant from live non-related donor | N | ||
| 0.93 | Transplant from cadaver | N | ||
| 27.64 | Insertion of palatal implant | N | ||
| 37.68 | Insertion of percutaneous external heart assist device | Y | 5 | 104, 105 |
| 37.90 | Insertion of left atrial appendage device | N | 5 | 518 |
| 44.38 | Laparoscopic gastroenterostomy | Y | 5 | 120 |
| 6 | 154, 155, 156 | |||
| 7 | 201 | |||
| 10 | 288 | |||
| 17 | 406,407, 539, | |||
| 540 | ||||
| 44.67 | Laparoscopic procedures for creation of | Y | 6 | 154, 155, 156 |
| esophagogastric sphincteric competence | 21 | 442,443 | ||
| 24 | 486 | |||
| 44.68 | Laparoscopic gastroplasty | Y | 6 | 154, 155, 156 |
| 10 | 288 | |||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 44.95 | Laparoscopic gastric restrictive procedure | Y | 10 | 288 |
| 44.96 | Laparoscopic revision of gastric restrictive procedure | Y | 10 | 288 |
| 44.97 | Laparoscopic removal of gastric restrictive device(s) | Y | 10 | 288 |
| 44.98 | (Laparoscopic) adjustment of size of adjustable gastric restrictive device | Y | 10 | 288 |
| 81.65 | Vertebroplasty | Y | 8 | 233,234 |
| 21 | 442,443 | |||
| 24 | 486 | |||
| 81.66 | Kyphoplasty | Y | 8 | 233,234 |
| 21 | 442,443 | |||
| 24 | 486 | |||
| 84.53 | Implantation of internal limb lengthening device with kinetic distraction | N | ||
| 84.54 | Implantation of other internal limb lengthening device | N | ||
| 84.55 | Insertion of bone void filler | N | ||
| 84.59 | Insertion of other spinal devices | Y | 1 | 531,532 |
| 8 | 499,500 | |||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 84.60 | Insertion of spinal disc prosthesis, not | Y | 1 | 531,532 |
| otherwise specified | 8 | 499,500 | ||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 84.61 | Insertion of partial spinal disc prosthesis, | Y | 1 | 531,532 |
| cervical | 8 | 499,500 | ||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 84.62 | Insertion of total spinal disc prosthesis, | Y | 1 | 531,532 |
| cervical | 8 | 499,500 | ||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 84.63 | Insertion of spinal disc prosthesis, thoracic | Y | 1 | 531,532 |
| 8 | 499,500 | |||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 84.64 | Insertion of partial spinal disc prosthesis, | Y | 1 | 531,532 |
| lumbosacral | 8 | 499,500 | ||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 84.65 | Insertion of total spinal disc prosthesis, | Y | 1 | 531,532 |
| lumbosacral | 8 | 499,500 | ||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 84.66 | Revision or replacement of artificial spinal | Y | 1 | 531,532 |
| disc prosthesis, cervical | 8 | 499,500 | ||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 84.67 | Revision or replacement of artificial spinal | Y | 1 | 531,532 |
| disc prosthesis, thoracic | 8 | 499,500 | ||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 84.68 | Revision or replacement of artificial spinal | Y | 1 | 531,532 |
| disc prosthesis, lumbosacral | 8 | 499,500 | ||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 84.69 | Revision or replacement of artificial spinal | Y | 1 | 531,532 |
| disc prosthesis, not otherwise specified | 8 | 499,500 | ||
| 21 | 442,443 | |||
| 24 | 486 | |||
| 86.94 | Insertion or replacement of single array neurostimulator pulse generator | Y | 7,8 | |
| 86.95 | Insertion or replacement of dual array neurostimulator pulse generator | Y | 1 | 7,8 |
| 86.96 | Insertion or replacement of other neurostimulator pulse generator | Y | 1 | 7,8 |
| 89.49 | Automatic implantable cardioverter/defibrillator (AI CD) check | N | ||
| 99.78 | Aquapheresis | N | ||
| TABLE 6C - INVALID DIAGNOSIS CODES | ||||
| Diagnosis | ||||
| Code | Description | CC | MDC | DRG |
| 66.40 | West Nile Fever | N | 18 | 421,422 |
| 252.00 | Hyperparathyroidism | N | 10 | 300,301 |
| 347.00 | Cataplexy and narcolepsy | N | 1 | 34,35 |
| 521.10 | Excessive attrition | N | PRE | 482 |
| 3 | 185, 186, 187 | |||
| 521.20 | Abrasion | N | PRE | 482 |
| 3 | 185, 186, 187 | |||
| 521.30 | Erosion | N | PRE | 482 |
| 3 | 185, 186, 187 | |||
| 521.40 | Pathological resorption | N | PRE | 482 |
| 3 | 185, 186, 187 | |||
| 523.20 | Gingival recession | N | PRE | 482 |
| 3 | 185, 186, 187 | |||
| 524.20 | Anomalies of dental arch relationship | N | PRE | 482 |
| 3 | 185, 186, 187 | |||
| 524.30 | Anomalies of tooth position | N | PRE | 482 |
| 3 | 185, 186, 187 | |||
| 524.50 | Dentofacial functional abnormalities | N | PRE | 482 |
| 3 | 185, 186, 187 | |||
| 524.80 | Other specified dentofacial anomalies | N | PRE | 482 |
| 3 | 185, 186, 187 | |||
| 525.20 | Atrophy of edentulous alveolar ridge | N | PRE | 482 |
| 3 | 185, 186, 187 | |||
| 528.70 | Other disturbances of oral epithelium, including tongue | N | PRE | 482 |
| 3 | 185, 186, 187 | |||
| 588.80 | Other specified disorders resulting from impaired renal | N | 11 | 331,332,333 |
| function | ||||
| 618.00 | Prolapse of vaginal walls without mention of uterine | N | 13 | 358,359,369 |
| prolapse | ||||
| 618.80 | Other specified genital prolapse | N | 13 | 358,359,369 |
| 621.30 | Endometrial cystic hyperplasia | N | 13 | 358,359,369 |
| 622.10 | Dysplasia of cevix (uteri) | N | 13 | 358,359,369 |
| 707.00 | Decubitus ulcer | Y | 5 | 1211 |
| 9 | 263,264,271 | |||
| 758.30 | Autosomal deletion syndromes | N | 19 | 429 |
| V01.7 | Other viral diseases | N | 23 | 467 |
| V46.1 | Respirator | Y | 23 | 467 |
| V72.3 | Gynecological examination | N | 23 | 467 |
| V72.4 | Pregnancy examination or test, pregnancy unconfirmed | N | 23 | 467 |
TABLE 6D - INVALID PROCEDURE CODES
There are no invalid procedure codes for FY 2005.
| TABLE 6E--REVISED DIAGNOSIS CODE TITLES | ||||
| Diagnosis Code | Description | CC | MDC | DRG |
| 41.82 | Bacteroides fragilis | N | 18 | 423 |
| 70.41 | Acute hepatitis C with hepatic coma | Y | 7 | 205,206 |
| 15 | 387 389 | |||
| 70.51 | Acute hepatitis C without mention | Y | 7 | 205,206 |
| of hepatic coma | 15 | 387 389 | ||
| 250.00 | Diabetes mellitus without mention | N | PRE | 512,513 |
| of complication, type II or | 10 | 294,295 | ||
| unspecified type, not stated as | ||||
| uncontrolled | ||||
| 250.01 | Diabetes mellitus without mention | Y | PRE | 512,513 |
| of complication, type I [juvenile | 10 | 294,295 | ||
| type], not stated as uncontrolled | ||||
| 250.02 | Diabetes mellitus without mention | Y | PRE | 512,513 |
| of complication, type II or | 10 | 294,295 | ||
| unspecified type, uncontrolled | ||||
| 250.03 | Diabetes mellitus without mention | Y | PRE | 512,513 |
| of complication, type I [juvenile | 10 | 294,295 | ||
| type], uncontrolled | ||||
| 250.10 | Diabetes with ketoacidosis, type II | N | PRE | 512,513 |
| or unspecified type, not stated as | 10 | 294,295 | ||
| uncontrolled | ||||
| 250.11 | Diabetes with ketoacidosis, type I | Y | PRE | 512,513 |
| [juvenile type], not stated as | 10 | 294,295 | ||
| uncontrolled | ||||
| 250.12 | Diabetes with ketoacidosis, type II | Y | PRE | 512,513 |
| or unspecified type, uncontrolled | 10 | 294,295 | ||
| 250.13 | Diabetes with ketoacidosis, type I | Y | PRE | 512,513 |
| [juvenile type], uncontrolled | 10 | 294,295 | ||
| 250.20 | Diabetes with hyperosmolarity, type | N | PRE | 512,513 |
| II or unspecified type, not stated as | 10 | 294,295 | ||
| uncontrolled | ||||
| 250.21 | Diabetes with hyperosmolarity, type | Y | PRE | 512,513 |
| I [juvenile type], not stated as | 10 | 294,295 | ||
| Diagnosis Code | Description | CC | MDC | DRG |
| uncontrolled | ||||
| 250.22 | Diabetes with hyperosmolarity, type | Y | PRE | 512,513 |
| II or unspecified type, uncontrolled | 10 | 294,295 | ||
| 250.23 | Diabetes with hyperosmolarity, type | Y | PRE | 512,513 |
| I [juvenile type], uncontrolled | 10 | 294,295 | ||
| 250.30 | Diabetes with other coma, type II or | N | PRE | 512,513 |
| unspecified type, not stated as | 10 | 294,295 | ||
| uncontrolled | ||||
| 250.31 | Diabetes with other coma, type I | Y | PRE | 512,513 |
| [juvenile type], not stated as | 10 | 294,295 | ||
| uncontrolled | ||||
| 250.32 | Diabetes with other coma, type II or | Y | PRE | 512,513 |
| unspecified type, uncontrolled | 10 | 294,295 | ||
| 250.33 | Diabetes with other coma, type I | Y | PRE | 512,513 |
| [juvenile type], uncontrolled | 10 | 294,295 | ||
| 250.40 | Diabetes with renal manifestations, | N | PRE | 512,513 |
| type II or unspecified type, not | 11 | 331,332,333 | ||
| stated as uncontrolled | ||||
| 250.41 | Diabetes with renal manifestations, | Y | PRE | 512,513 |
| type I [juvenile type], not stated as | 11 | 331,332,333 | ||
| uncontrolled | ||||
| 250.42 | Diabetes with renal manifestations, | Y | PRE | 512,513 |
| type II or unspecified type, | 11 | 331,332,333 | ||
| uncontrolled | ||||
| 250.43 | Diabetes with renal manifestations, | Y | PRE | 512,513 |
| type I [juvenile type], uncontrolled | 11 | 331,332,333 | ||
| 250.50 | Diabetes with ophthalmic | N | PRE | 512,513 |
| manifestations, type II or | 2 | 46,47,48 | ||
| unspecified type, not stated as | ||||
| uncontrolled | ||||
| 250.51 | Diabetes with ophthalmic | Y | PRE | 512,513 |
| manifestations, type I [juvenile | 2 | 46,47,48 | ||
| type], not stated as uncontrolled | ||||
| 250.52 | Diabetes with ophthalmic | Y | PRE | 512,513 |
| manifestations, type II or | 2 | 46,47,48 | ||
| unspecified type, uncontrolled | ||||
| 250.53 | Diabetes with ophthalmic | Y | PRE | 512,513 |
| manifestations, type I [juvenile | 2 | 46,47,48 | ||
| type], uncontrolled | ||||
| 250.60 | Diabetes with neurological | N | PRE | 512,513 |
| manifestations, type II or | 1 | 18, 19 | ||
| unspecified type, not stated as | ||||
| uncontrolled | ||||
| 250.61 | Diabetes with neurological | Y | PRE | 512,513 |
| manifestations, type I [juvenile | 1 | 18, 19 | ||
| type], not stated as uncontrolled | ||||
| 250.62 | Diabetes with neurological | Y | PRE | 512,513 |
| manifestations, type II or | 1 | 18, 19 | ||
| unspecified type, uncontrolled | ||||
| 250.63 | Diabetes with neurological | Y | PRE 1 | 512,513 |
| manifestations, type I [juvenile | 18, 19 | |||
| type], uncontrolled | ||||
| 250.70 | Diabetes with peripheral circulatory | N | PRE | 512,513 |
| disorders, type II or unspecified | 5 | 130, 131 | ||
| type, not stated as uncontrolled | ||||
| 250.71 | Diabetes with peripheral circulatory | Y | PRE | 512,513 |
| disorders, type I [juvenile type], not | 5 | 130, 131 | ||
| stated as uncontrolled | ||||
| 250.72 | Diabetes with peripheral circulatory | Y | PRE | 512,513 |
| disorders, type II or unspecified | 5 | 130, 131 | ||
| type, uncontrolled | ||||
| 250.73 | Diabetes with peripheral circulatory | Y | PRE | 512,513 |
| disorders, type I [juvenile type], | 5 | 130, 131 | ||
| uncontrolled | ||||
| 250.80 | Diabetes with other specified | N | PRE | 512,513 |
| manifestations, type II or | 10 | 294,295 | ||
| unspecified type, not stated as | ||||
| uncontrolled | ||||
| 250.81 | Diabetes with other specified | Y | PRE | 512,513 |
| manifestations, type I [juvenile | 10 | 294,295 | ||
| type], not stated as uncontrolled | ||||
| 250.82 | Diabetes with other specified | Y | PRE | 512,513 |
| manifestations, type II or | 10 | 294,295 | ||
| unspecified type, uncontrolled | ||||
| 250.83 | Diabetes with other specified | Y | PRE | 512,513 |
| manifestations, type I [juvenile | 10 | 294,295 | ||
| type], uncontrolled | ||||
| 250.90 | Diabetes with unspecified | N | PRE | 512,513 |
| complication, type II or unspecified | 10 | 294,295 | ||
| type, not stated as uncontrolled | ||||
| 250.91 | Diabetes with unspecified | Y | PRE | 512,513 |
| complication, type I [juvenile type], | 10 | 294,295 | ||
| not stated as uncontrolled | ||||
| 250.92 | Diabetes with unspecified | Y | PRE | 512,513 |
| complication, type II or unspecified | 10 | 294,295 | ||
| type, uncontrolled | ||||
| 250.93 | Diabetes with unspecified | Y | PRE | 512,513 |
| complication, type I [juvenile type], | 10 | 294,295 | ||
| uncontrolled | ||||
| 286.50 | Hemorrhagic disorder due to | Y | 16 | 397 |
| intrinsic circulating anticoagulants | ||||
| 290.40 | Vascular dementia, uncomplicated | N | 19 | 429 |
| 290.41 | Vascular dementia, with delirium | N | 19 | 429 |
| 290.42 | Vascular dementia, with delusions | N | 19 | 429 |
| 290.43 | Vascular dementia, with depressed | N | 19 | 429 |
| mood | ||||
| 291.10 | Alcohol-induced persisting amnestic | Y | 20 | 521,522,523 |
| disorder | ||||
| 291.20 | Alcohol-induced persisting | Y | 20 | 521,522,523 |
| dementia | ||||
| 291.30 | Alcohol-induced psychotic disorder | Y | 20 | 521,522,523 |
| with hallucinations | ||||
| 291.50 | Alcohol-induced psychotic disorder | N | 20 | 521,522,523 |
| with delusions | ||||
| 291.89 | Other specified alcohol-induced | Y | 20 | 521,522,523 |
| mental disorders | ||||
| 291.90 | Unspecified alcohol-induced mental | Y | 20 | 521,522,523 |
| disorders | ||||
| 292.00 | Drug withdrawal | Y | 15 | 3871 3891 |
| 20 | 521,522,523 | |||
| 292.11 | Drug-induced psychotic disorder | Y | 20 | 521,522,523 |
| with delusions | ||||
| 292.12 | Drug-induced psychotic disorder | Y | 20 | 521,522,523 |
| with hallucinations | ||||
| 292.82 | Drug-induced persisting dementia | Y | 20 | 521,522,523 |
| 292.83 | Drug-induced persisting amnestic | Y | 20 | 521,522,523 |
| disorder | ||||
| 292.84 | Drug-induced mood disorder | Y | 20 | 521,522,523 |
| 293.00 | Delirium due to conditions | N | 19 | 425 |
| classified elsewhere | ||||
| 293.81 | Psychotic disorder with delusions in | Y | 19 | 429 |
| conditions classified elsewhere | ||||
| 293.82 | Psychotic disorder with | Y | 19 | 429 |
| hallucinations in conditions | ||||
| classified elsewhere | ||||
| 293.83 | Mood disorder in conditions | Y | 19 | 429 |
| classified elsewhere | ||||
| 293.84 | Anxiety disorder in conditions | Y | 19 | 429 |
| classified elsewhere | ||||
| 293.89 | Other specified transient mental | N | 19 | 429 |
| disorders due to conditions | ||||
| classified elsewhere, other | ||||
| 293.90 | Unspecified transient mental | N | 19 | 425 |
| disorder in conditions classified | ||||
| elsewhere | ||||
| 294.00 | Amnestic disorder in conditions | N | 19 | 429 |
| classified elsewhere | ||||
| 294.80 | Other persistent mental disorders | N | 19 | 429 |
| due to conditions classified | ||||
| elsewhere | ||||
| 294.90 | Unspecified persistent mental | N | 19 | 429 |
| disorders due to conditions | 25 | 4892 | ||
| classified elsewhere | ||||
| 295.40 | Schizophreniform disorder, | Y | 19 | 430 |
| unspecified | ||||
| 295.41 | Schizophreniform disorder, | Y | 19 | 430 |
| sub chronic | ||||
| 295.42 | Schizophreniform disorder, chronic | Y | 19 | 430 |
| 295.43 | Schizophreniform disorder, | Y | 19 | 430 |
| subchronic with acute exacerbation | ||||
| 295.44 | Schizophreniform disorder, chronic | Y | 19 | 430 |
| with acute exacerbation | ||||
| 295.45 | Schizophreniform disorder, in | N | 19 | 430 |
| remission | ||||
| 295.60 | Schizophrenic disorders, residual | Y | 19 | 430 |
| type, unspecified | ||||
| 295.61 | Schizophrenic disorders, residual | Y | 19 | 430 |
| type, sub chronic | ||||
| 295.62 | Schizophrenic disorders, residual | Y | 19 | 430 |
| type, chronic | ||||
| 295.63 | Schizophrenic disorders, residual | Y | 19 | 430 |
| type, subchronic with acute | ||||
| exacerbation | ||||
| 295.64 | Schizophrenic disorders, residual | Y | 19 | 430 |
| type, chronic with acute | ||||
| exacerbation | ||||
| 295.65 | Schizophrenic disorders, residual | N | 19 | 430 |
| type, in remission | ||||
| 295.70 | Schizoaffective disorder, | Y | 19 | 430 |
| unspecified | ||||
| 295.71 | Schizoaffective disorder, subchronic | Y | 19 | 430 |
| 295.72 | Schizoaffective disorder, chronic | Y | 19 | 430 |
| 295.73 | Schizoaffective disorder, sub chronic | Y | 19 | 430 |
| with acute exacerbation | ||||
| 295.74 | Schizoaffective disorder, chronic | Y | 19 | 430 |
| with acute exacerbation | ||||
| 295.75 | Schizoaffective disorder, in | N | 19 | 430 |
| remission | ||||
| 296.00 | Bipolar I disorder, single manic | N | 19 | 430 |
| episode, unspecified | ||||
| 296.01 | Bipolar I disorder, single manic | N | 19 | 430 |
| episode, mild | ||||
| 296.02 | Bipolar I disorder, single manic | N | 19 | 430 |
| episode, moderate | ||||
| 296.03 | Bipolar I disorder, single manic | N | 19 | 430 |
| episode, severe, without mention of | ||||
| psychotic behavior | ||||
| 296.04 | Bipolar I disorder, single manic | Y | 19 | 430 |
| episode, severe, specified as with | ||||
| psychotic behavior | ||||
| 296.05 | Bipolar I disorder, single manic | N | 19 | 430 |
| episode, in partial or unspecified | ||||
| remission | ||||
| 296.06 | Bipolar I disorder, single manic | N | 19 | 430 |
| episode, in full remission | ||||
| 296.40 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) manic, | ||||
| unspecified | ||||
| 296.41 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) manic, mild | ||||
| 296.42 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) manic, | ||||
| moderate | ||||
| 296.43 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) manic, severe, | ||||
| without mention of psychotic | ||||
| behavior | ||||
| 296.44 | Bipolar I disorder, most recent | Y | 19 | 430 |
| episode (or current) manic, severe, | ||||
| specified as with psychotic behavior | ||||
| 296.45 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) manic, in partial | ||||
| or unspecified remission | ||||
| 296.46 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) manic, in full | ||||
| remission | ||||
| 296.50 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) depressed, | ||||
| unspecified | ||||
| 296.51 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) depressed, mild | ||||
| 296.52 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) depressed, | ||||
| moderate | ||||
| 296.53 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) depressed, | ||||
| severe, without mention of | ||||
| psychotic behavior | ||||
| 296.54 | Bipolar I disorder, most recent | Y | 19 | 430 |
| episode (or current) depressed, | ||||
| severe, specified as with psychotic | ||||
| behavior | ||||
| 296.55 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) depressed, in | ||||
| partial or unspecified remission | ||||
| 296.56 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) depressed, in | ||||
| full remission | ||||
| 296.60 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) mixed, | ||||
| unspecified | ||||
| 296.61 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) mixed, mild | ||||
| 296.62 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) mixed, | ||||
| moderate | ||||
| 296.63 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) mixed, severe, | ||||
| without mention of psychotic | ||||
| behavior | ||||
| 296.64 | Bipolar I disorder, most recent | Y | 19 | 430 |
| episode (or current) mixed, severe, | ||||
| specified as with psychotic behavior | ||||
| 296.65 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) mixed, in partial | ||||
| or unspecified remission | ||||
| 296.66 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) mixed, in full | ||||
| remission | ||||
| 296.70 | Bipolar I disorder, most recent | N | 19 | 430 |
| episode (or current) unspecified | ||||
| 296.80 | Bipolar disorder, unspecified | N | 19 | 430 |
| 296.89 | Other and unspecified bipolar | N | 19 | 430 |
| disorders, other | ||||
| 296.90 | Unspecified episodic mood disorder | N | 19 | 430 |
| 296.99 | Other specified episodic mood | N | 19 | 430 |
| disorder | ||||
| 297.10 | Delusional disorder | N | 19 | 430 |
| 297.30 | Shared psychotic disorder | N | 19 | 430 |
| 299.00 | Autistic disorder, current or active | Y | 19 | 429 |
| state | ||||
| 299.01 | Autistic disorder, residual state | N | 19 | 429 |
| 299.10 | Childhood disintegrative disorder, | Y | 19 | 429 |
| current or active state | ||||
| 299.11 | Childhood disintegrative disorder, | N | 19 | 429 |
| residual state | ||||
| 299.80 | Other specified pervasive | Y | 19 | 430 |
| developmental disorders, current or | ||||
| active state | ||||
| 299.81 | Other specified pervasive | N | 19 | 430 |
| developmental disorders, residual | ||||
| state | ||||
| 299.90 | Unspecified pervasive | Y | 19 | 430 |
| developmental disorder, current or | ||||
| active state | ||||
| 299.91 | Unspecified pervasive | N | 19 | 430 |
| developmental disorder, residual | ||||
| state | ||||
| 300.01 | Panic disorder without agoraphobia | N | 19 | 425 |
| 300.12 | Dissociative amnesia | N | 19 | 425 |
| 300.13 | Dissociative fugue | N | 19 | 425 |
| 300.14 | Dissociative identity disorder | N | 19 | 428 |
| 300.16 | Factitious disorder with | N | 19 | 425 |
| predominantly psychological signs | ||||
| and symptoms | ||||
| 300.21 | Agoraphobia with panic disorder | N | 19 | 427 |
| 300.29 | Other isolated or specific phobias | N | 19 | 427 |
| 300.40 | Dysthymic disorder | N | 19 | 426 |
| 300.60 | Depersonalization disorder | N | 19 | 427 |
| 300.89 | Other somatoform disorders | N | 19 | 427 |
| 300.90 | Unspecified nonpsychotic mental | N | 19 | 425 |
| disorder | ||||
| 301.22 | Schizotypal personality disorder | N | 19 | 428 |
| 301.40 | Obsessive-compulsive personality | N | 19 | 428 |
| disorder | ||||
| 301.81 | Narcissistic personality disorder | N | 19 | 428 |
| 301.82 | Avoidant personality disorder | N | 19 | 428 |
| 301.83 | Borderline personality disorder | N | 19 | 428 |
| 302.00 | Ego-dystonic sexual orientation | N | 19 | 432 |
| 302.30 | Transvestic fetishism | N | 19 | 432 |
| 302.60 | Gender identity disorder in children | N | 19 | 432 |
| 302.71 | Hypoactive sexual desire disorder | N | 19 | 432 |
| 302.73 | Female orgasmic disorder | N | 19 | 432 |
| 302.74 | Male orgasmic disorder | N | 19 | 432 |
| 302.75 | Premature ejaculation | N | 19 | 432 |
| 302.76 | Dyspareunia, psychogenic | N | 19 | 432 |
| 302.85 | Gender identity disorder in | N | 19 | 432 |
| adolescents or adults | ||||
| 304.10 | Sedative, hypnotic or anxiolytic | Y | 20 | 521,522,523 |
| dependence, unspecified | ||||
| 304.11 | Sedative, hypnotic or anxiolytic | Y | 20 | 521,522,523 |
| dependence, continuous | ||||
| 304.12 | Sedative, hypnotic or anxiolytic | Y | 20 | 521,522,523 |
| dependence, episodic | ||||
| 304.13 | Sedative, hypnotic or anxiolytic | N | 20 | 521,522,523 |
| dependence, in remission | ||||
| 305.40 | Sedative, hypnotic or anxiolytic | Y | 20 | 521,522,523 |
| abuse, unspecified | ||||
| 305.41 | Sedative, hypnotic or anxiolytic | Y | 20 | 521,522,523 |
| abuse, continuous | ||||
| 305.42 | Sedative, hypnotic or anxiolytic | Y | 20 | 521,522,523 |
| abuse, episodic | ||||
| 305.43 | Sedative, hypnotic or anxiolytic | N | 20 | 521,522,523 |
| abuse, in remission | ||||
| 307.00 | Stuttering | N | 19 | 432 |
| 307.21 | Transient tic disorder | N | 1 | 34,35 |
| 307.22 | Chronic motor or vocal tic disorder | N | 1 | 34,35 |
| 307.23 | Tourette's disorder | N | 1 | 34, 35 |
| 307.30 | Stereotypic movement disorder | N | 19 | 432 |
| 307.45 | Circadian rhythm sleep disorder | N | 19 | 432 |
| 307.46 | Sleep arousal disorder | N | 19 | 432 |
| 307.51 | Bulimia nervosa | N | 19 | 432 |
| 307.53 | Rumination disorder | N | 19 | 427 |
| 307.89 | Other, pain disorder related to | N | 19 | 427 |
| psychological factors | ||||
| 309.00 | Adjustment disorder with depressed | N | 19 | 426 |
| mood | ||||
| 309.24 | Adjustment disorder with anxiety | N | 19 | 427 |
| 309.28 | Adjustment disorder with mixed | N | 19 | 427 |
| anxiety and depressed mood | ||||
| 309.30 | Adjustment disorder with | N | 19 | 427 |
| disturbance of conduct | ||||
| 309.40 | Adjustment disorder with mixed | N | 19 | 427 |
| disburbance of emotions and | ||||
| conduct | ||||
| 309.81 | Posttraumatic stress disorder | N | 19 | 427 |
| 310.10 | Personality change due to conditions | N | 19 | 429 |
| classified elsewhere | ||||
| 313.23 | Selective mutism | N | 19 | 431 |
| 313.81 | Oppositional defiant disorder | N | 19 | 431 |
| 313.90 | Unspecified emotional disturbance | N | 19 | 431 |
| of childhood or adolescence | ||||
| 315.10 | Mathematics disorder | N | 19 | 431 |
| 315.31 | Expressive language disorder | N | 19 | 431 |
| 315.32 | Mixed receptive-expressive | N | 19 | 431 |
| language disorder | ||||
| 315.40 | Developmental coordination | N | 19 | 431 |
| disorder | ||||
| 521.70 | Intrinsic posteruptive color changes | N | PRE | 482 |
| 3 | 185, 186, 187 | |||
| 760.70 | Noxious influences affecting fetus | N | 15 | 390 |
| or newborn via placenta or breast | ||||
| milk, unspecified noxious substance | ||||
| 760.71 | Noxious influences affecting fetus | N | 15 | 390 |
| or newborn via placenta or breast | ||||
| milk, alcohol | ||||
| 760.72 | Noxious influences affecting fetus | N | 15 | 390 |
| or newborn via placenta or breast | ||||
| milk, narcotics | ||||
| 760.73 | Noxious influences affecting fetus | N | 15 | 390 |
| or newborn via placenta or breast | ||||
| milk, hallucinogenic agents | ||||
| 760.74 | Noxious influences affecting fetus | N | 15 | 390 |
| or newborn via placenta or breast | ||||
| milk, anti-infectives | ||||
| 760.75 | Noxious influences affecting fetus | N | 15 | 390 |
| or newborn via placenta or breast | ||||
| milk, cocaine | ||||
| 760.76 | Noxious influences affecting fetus | N | 15 | 390 |
| or newborn via placenta or breast | ||||
| milk, diethylstilbestrol [DES] | ||||
| 760.79 | Noxious influences affecting fetus | N | 15 | 390 |
| or newborn via placenta or breast | ||||
| milk, other | ||||
| 780.80 | Generalized hyperhidrosis | N | 9 | 283-284 |
| 25 | 490 | |||
| 795.00 | Abnormal glandular Papanicolaou | N | 13 | 358,359,369 |
| smear of cervix | ||||
| 795.01 | Papanicolaou smear of cervix with | N | 13 | 358,359,369 |
| atypical squamous cells of | ||||
| undetermined significance (ASC-US) | ||||
| 795.02 | Papanicolaou smear of cervix with | N | 13 | 358,359,369 |
| atypical squamous cells cannot | ||||
| exclude high grade squamous | ||||
| intraepitheliallesion (ASC-H) | ||||
| 795.09 | Other abnormal Papanicolaou smear | N | 13 | 358,359,369 |
| of cervix and cervical HPV | ||||
| V07.4 | Hormone replacement therapy | N | 23 | 467 |
| (postmenopausal) | ||||
| TABLE 6F--REVISED PROCEDURE CODE TITLES | ||||
| Procedure Code | Description | OR | MDC | DRG |
| 0.55 | Insertion of drug-eluting peripheral vessel | N | ||
| stent( s ) | ||||
| 1.22 | Removal of intracranial neurostimulator | Y | 1 | 1,2,3 |
| lead(s) | 17 | 406,407,539,540 | ||
| 17 | ||||
| 2.93 | Implantation or replacement of intracranial | Y | I | 1,2,3 |
| neurostimulator lead( s) | 17 | 406,407,539,540 | ||
| 442,443 | ||||
| 21 | 486 | |||
| 24 | ||||
| 3.93 | Implantation or replacement of spinal | Y | 1 | 531,532 |
| neurostimulator lead( s) | 8 | 499,500 | ||
| 11 | 315 | |||
| 12 | 344,345 | |||
| 13 | 365 | |||
| 17 | 406, 407, | |||